Topical Finasteride in the Treatment of Idiopathic Hirsutism

Overview

the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism

Full Title of Study: “The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)

Interventions

  • Drug: topical finasteride
    • 0.2%topical(cream)finasteride twice a day for six months

Clinical Trial Outcome Measures

Primary Measures

  • the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication
    • Time Frame: 6 months

Secondary Measures

  • the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication
    • Time Frame: 6 months

Participating in This Clinical Trial

Inclusion Criteria

  • Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation – Normal serum prolactin Exclusion Criteria:

  • Pregnancy – Simultaneous use of other drugs for the treatment of hirsutism

Gender Eligibility: Female

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Iran University of Medical Sciences
  • Collaborator
    • Firuzgar hospital affiliated to Iran University of Medical Sciences
  • Overall Official(s)
    • iraj heydari, professor assistant, Study Director, endocrine and metabolism centre of Iran University of Medical Sciences

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.